Literature DB >> 10768228

[Socioeconomic aspects of urinary calculi and metaphylaxis of urinary calculi].

W L Strohmaier1.   

Abstract

A calculation model was developed for the cost of stone therapy and metaphylaxis in Germany based on estimates of stone incidence, types and recurrence rates, actual costs for stone removal and metaphylaxis (based on data from a district of the social health care system). There are 200,000 stone recurrences per year in Germany. Cost for treatment of these stones amount to $687,000,000. Stone metaphylaxis reduces the recurrence rate by some 40%. The annual cost for stone removal could be lowered by $275,300,000. Metabolic evaluation/metaphylaxis amount to $70,100,000 per year, resulting in an net saving of $205,200,000. In 1997, there were 96 days off-work per stone patient resulting in 5,800,000 days off-work in Germany per year. Metaphylaxis in stone formers can lower health care cost significantly. Although health care conditions may vary from country to country, in principle this calculation model is applicable also to other countries.

Entities:  

Mesh:

Year:  2000        PMID: 10768228     DOI: 10.1007/s001200050026

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

Review 1.  [Alkaline citrates in urology. A status report].

Authors:  L Rinnab; R E Hautmann; M Straub
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

Review 2.  [Prevention of nephrolithiasis. Established strategies and new concepts].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

Review 3.  [Recurrence prevention of urolithiasis with respect to economic aspects].

Authors:  R Siener; N Laube; W L Strohmaier
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

Review 4.  Assessment of stone composition in the management of urinary stones.

Authors:  Kittinut Kijvikai; J J M de la Rosette
Journal:  Nat Rev Urol       Date:  2010-12-07       Impact factor: 14.432

5.  [Economic aspects of evidence-based metaphylaxis].

Authors:  W L Strohmaier
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

6.  The economics of stone disease.

Authors:  Noah E Canvasser; Peter Alken; Michael Lipkin; Stephen Y Nakada; Hiren S Sodha; Abdulkadir Tepeler; Yair Lotan
Journal:  World J Urol       Date:  2017-01-20       Impact factor: 4.226

Review 7.  Is prevention of stone recurrence financially worthwhile?

Authors:  W G Robertson
Journal:  Urol Res       Date:  2006-02-03

Review 8.  Economic Considerations in the Management of Nephrolithiasis.

Authors:  Daniel Roberson; Colin Sperling; Ankur Shah; Justin Ziemba
Journal:  Curr Urol Rep       Date:  2020-03-31       Impact factor: 3.092

Review 9.  Economics of stone disease/treatment.

Authors:  Walter Ludwig Strohmaier
Journal:  Arab J Urol       Date:  2012-03-22

10.  Comparison of prone vs. supine unenhanced CT imaging in patients with clinically suspected ureterolithiasis.

Authors:  Matthias Meissnitzer; Thomas Meissnitzer; Stephan Hruby; Stefan Hecht; Andreas Gutzeit; Laura Holzer-Frühwald; Klaus Hergan; Rosemarie Forstner
Journal:  Abdom Radiol (NY)       Date:  2017-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.